STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 5, 2026, 04:24 PM

USANA Q1 Net Sales $250M; EPS $0.41; Reiterates FY26 Guidance

AI Summary

USANA Health Sciences reported flat net sales of $250 million for the first quarter of 2026, while net earnings decreased 20% to $7.5 million and diluted EPS fell 16% to $0.41. Despite year-over-year declines in profitability and active customers in its Core Nutritional and Hiya segments, the company highlighted significant sequential improvements and strong growth in its Rise Wellness segment, driven by the Protein Pop Plus launch at Costco. USANA reiterated its full-year 2026 guidance, expressing confidence in its strategic transformation to a diversified omnichannel health and wellness enterprise.

Key Highlights

  • Net sales were $250 million, flat year-over-year, with a sequential increase of 11%.
  • Net earnings decreased 20% year-over-year to $7.5 million, and diluted EPS fell 16% to $0.41.
  • Core Nutritional business net sales were $204 million (-3% YoY, +7% sequentially), with active customers at 404,000 (-12% YoY, +4% sequentially).
  • Hiya Health net sales were $32 million (-13% YoY, +7% sequentially), with active monthly subscribers at 186,000 (-17% YoY, +2% sequentially).
  • Rise Wellness net sales surged 741% year-over-year and 143% sequentially to $14 million, driven by Protein Pop Plus launch at Costco.
  • The company ended the quarter with $163 million in cash and cash equivalents and $14 million of debt.
  • USANA reiterated its fiscal year 2026 guidance for consolidated net sales of $925 million to $1.0 billion and diluted EPS of $1.11 to $1.45.
  • Hiya launched in Canada and the UK, and its products are now available at Target, marking its first physical retail presence.
USNA
Medicinal Chemicals and Botanical Products
USANA HEALTH SCIENCES INC

Price Impact